Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
D DERMATOLOGICALS
D05 ANTIPSORIATICS
D05A ANTIPSORIATICS FOR TOPICAL USE
D05AD Psoralens for topical use
D05AD02 Methoxsalen
D00139 Methoxsalen (JP18/USP) <JP/US>
D05B ANTIPSORIATICS FOR SYSTEMIC USE
D05BA Psoralens for systemic use
D05BA02 Methoxsalen
D00139 Methoxsalen (JP18/USP) <JP/US>
USP drug classification [BR:br08302]
Dermatological Agents
Dermatological Agents, Other
Psoriasis Agents
Methoxsalen
D00139 Methoxsalen (JP18/USP)
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
26 Epidermides
269 Miscellaneous
2699 Others
D00139 Methoxsalen (JP18/USP)
Drug groups [BR:br08330]
Metabolizing enzyme inhibitor
DG01525 CYP2A6 inhibitor
D00139 Methoxsalen
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D00139 Methoxsalen
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D00139